Phase II trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration-resistant prostate cancer
多西他赛、贝伐珠单抗、来那度胺和泼尼松治疗转移性去势抵抗性前列腺癌患者的II期临床试验
期刊:Bju International
影响因子:4.4
doi:10.1111/bju.13412
Madan, Ravi A; Karzai, Fatima H; Ning, Yang-Min; Adesunloye, Bamidele A; Huang, Xuan; Harold, Nancy; Couvillon, Anna; Chun, Guinevere; Cordes, Lisa; Sissung, Tristan; Beedie, Shaunna L; Dawson, Nancy A; Theoret, Marc R; McLeod, David G; Rosner, Inger; Trepel, Jane B; Lee, Min-Jung; Tomita, Yusuke; Lee, Sunmin; Chen, Clara; Steinberg, Seth M; Arlen, Philip M; Gulley, James L; Figg, William D; Dahut, William L
